SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

JAMA Netw Open. 2024;7(1):e2350036.

Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis.

, , , , , , , , , , , , , , , , , , , , , , , , , , , ,

제1저자 양석훈, 강지훈 · 교신저자 구본권

PMID 38170524 PMC10765263 DOI 10.1001/jamanetworkopen.2023.50036 IF 11.7 순환기내과
소속 (20)
  1. Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  2. The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  3. Samsung Medical Center, Seoul, Republic of Korea.
  4. Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
  5. Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
  6. Kangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.
  7. Kyung Hee University Hospital, Seoul, Republic of Korea.
  8. Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  9. Hangzhou Normal University Affiliated Hospital, Hangzhou, China.
  10. The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  11. The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  12. Zhejiang Hospital, Hangzhou, China.
  13. The Third Clinical Institute Affiliated To Wenzhou Medical University, Wenzhou, China.
  14. Ningbo First Hospital, Ningbo, China.
  15. The Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
  16. Wonju Severance Christian Hospital, Wonju, Gangwon-Do, Republic of Korea.
  17. Ajou University Hospital, Suwon, Republic of Korea.
  18. Yeungnam University Medical Center, Daegu, Republic of Korea.
  19. Uijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-Do, Republic of Korea.
  20. Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Abstract

IMPORTANCE Treatment strategies for intermediate coronary lesions guided by fractional flow reserve (FFR) and intravascular ultrasonography (IVUS) have shown comparable outcomes. Identifying low-risk deferred vessels to ensure the safe deferral of percutaneous coronary intervention (PCI) and high-risk revascularized vessels that necessitate thorough follow-up can help determine optimal treatment strategies.

OBJECTIVES To investigate outcomes according to treatment types and FFR and IVUS parameters after FFR- or IVUS-guided treatment.

DESIGN, SETTING, AND PARTICIPANTS This cohort study included patients with intermediate coronary stenosis from the Fractional Flow Reserve and Intravascular Ultrasound-Guided Intervention Strategy for Clinical Outcomes in Patients With Intermediate Stenosis (FLAVOUR) trial, an investigator-initiated, prospective, open-label, multicenter randomized clinical trial that assigned patients into an IVUS-guided strategy (which recommended PCI for minimum lumen area [MLA] ≤3 mm2 or 3 mm2 to 4 mm2 with plaque burden [PB] ≥70%) or an FFR-guided strategy (which recommended PCI for FFR ≤0.80). Data were analyzed from November to December 2022.

EXPOSURES FFR or IVUS parameters within the deferred and revascularized vessels.

MAIN OUTCOMES AND MEASURES The primary outcome was target vessel failure (TVF), a composite of cardiac death, target vessel myocardial infarction, and revascularization at 2 years.

RESULTS A total of 1619 patients (mean [SD] age, 65.1 [9.6] years; 1137 [70.2%] male) with 1753 vessels were included in analysis. In 950 vessels for which revascularization was deferred, incidence of TVF was comparable between IVUS and FFR groups (3.8% vs 4.1%; P = .72). Vessels with FFR greater than 0.92 in the FFR group and MLA greater than 4.5 mm2 or PB of 58% or less in the IVUS group were identified as low-risk deferred vessels, with a decreased risk of TVF (hazard ratio [HR], 0.25 [95% CI, 0.09-0.71]; P = .009). In 803 revascularized vessels, the incidence of TVF was comparable between IVUS and FFR groups (3.6% vs 3.7%; P = .95), which was similar in the revascularized vessels undergoing PCI optimization (4.2% vs 2.5%; P = .31). Vessels with post-PCI FFR of 0.80 or less in the FFR group or minimum stent area of 6.0 mm2 or less or with PB at stent edge greater than 58% in the IVUS group had an increased risk for TVF (HR, 7.20 [95% CI, 3.20-16.21]; P < .001).

CONCLUSIONS AND RELEVANCE In this cohort study of patients with intermediate coronary stenosis, FFR- and IVUS-guided strategies showed comparable outcomes in both deferred and revascularized vessels. Binary FFR and IVUS parameters could further define low-risk deferred vessels and high-risk revascularized vessels.

Figures

Figure 1.
Figure 1. Study Recruitment Flowchart DCB indicates drug-coated balloon; FFR, fractional flow reserve; IVUS, intravascular ultrasonography; and PCI, percutaneous coronary intervention.
Figure 2.
Figure 2. Risk of Target Vessel Failure (TVF) in Deferred Vessels by Binary Fractional Flow Reserve (FFR) and Intravascular Ultrasonography (IVUS) Parameters A, Two-year rate of TVF in low-risk and high-risk deferred vessels defined by optimal cutoff values for estimating risk of TVF. Low-risk deferred vessels were defined as those with FFR greater than 0.92 or minimum lumen area (MLA) greater than 4.5 mm2 or plaque burden (PB) of 58% or less. B, Two-year rate of TVF of low-risk deferred vessels, high-risk deferred vessels, FFR-guided revascularized vessels, and IVUS-guided revascularized vessels.
Figure 3.
Figure 3. Risk of Target Vessel Failure (TVF) in Revascularized Vessels by Binary Fractional Flow Reserve (FFR) and Intravascular Ultrasonography (IVUS) Parameters After Percutaneous Coronary Intervention (PCI) A, Two-year rate of TVF in low-risk and high-risk revascularized vessels, defined by optimal cutoff values for estimating risk of TVF. High-risk revascularized vessels were defined as those with post-PCI FFR 0.80 or less or minimum stent area (MSA) 6.0 mm2 or less and plaque burden (PB) at stent edge greater than 58%. B, Two-year rate of TVF of low-risk revascularized vessels, high-risk revascularized vessels, FFR-guided deferred vessels, and IVUS-guided deferred vessels.

그림 출처: PubMed Central 공개 논문 (PMC10765263)

Conflict of interest statement

Conflict of Interest Disclosures: Dr Han reported receiving grants from Abbott Korea, Biosensors International Group, Biotronik, Boston Scientific, and Medtronic. Dr Koo reported receiving grants from Abbott Vascular, Boston Scientific, and Philips. Dr J. M. Lee reported receiving grants from Abbott and Philips. No other disclosures were reported.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
JAMA network open · eISSN 2574-3805
전자 출판
2024-01-02
MeSH
Aged · Female · Humans · Male · Cohort Studies · Coronary Angiography · Coronary Stenosis* / diagnostic imaging / therapy · Fractional Flow Reserve, Myocardial* · Percutaneous Coronary Intervention* · Plaque, Atherosclerotic* · Prospective Studies · Middle Aged · Multicenter Studies as Topic · Randomized Controlled Trials as Topic
참고문헌
39편